JCCS provides a forum for fundamental and translational research focusing either on intercellular or intracellular signaling pathways. Also of interest are manuscripts reporting studies aimed at understanding how cells interact with their surrounding environments, and how altered cellular behavior contributes to pathological states.
JCCS welcomes studies dealing with all aspects of remote cell signaling and communication, such as biological and biochemical studies of microvesicles and their signaling mechanisms in the context of tissue homeostasis and regeneration, as well as the identification of receptors and their ligands.

Research manuscripts can be published under the following sections to be selected upon manuscript submission:
MATRICELLULAR PROTEINS, SIGNALING MECHANISMS, FIBROSIS
BREAST CANCER, PANCREATIC CANCER, CANCER IMMUNOLOGY, CCN SIGNALING
MOLECULAR BIOLOGY OF CANCER: CERVICAL, BREAST AND HEAD & NECK CANCER
NERVOUS SYSTEM DEVELOPMENT; SYNAPTIC TRANSMISSION
MATRIX PATHOPHYSIOLOGY & TRANSCRIPTIONAL REGULATION
TRANSLATIONAL MOLECULAR PATHOLOGY
ANGIOGENESIS
AGING, CUTANEOUS BIOLOGY, TRANSLATIONAL STUDIES, PHOTOBIOLOGY
BREAST CANCER TRANSLATIONAL PATHOLOGY
SKELETAL DEVELOPMENT & RNA BIOLOGY
INFLAMMATION PROCESSES & TISSUE AND WOUND REPAIR
SIGNAL TRANSDUCTION; G PROTEIN-COUPLED RECEPTORS; MOLECULAR PHARMACOLOGY; PROTEIN PHOSPHORYLATION; LIPID MEDIATORS
MATRIX PROTEINS, AUTOIMMUNE DISEASE
IMMUNOLOGICAL METABOLISM
MUSCULOSKELETAL AGEING 
BIOINFORMATICS, METABOLOMICS, PROTEOMICS AND SIGNALING PATHWAYS
EXTRAEMBRYONIC AND TROPHOBLAST CELL LINEAGE DIFFERENTIATION; HEMOCHORIAL PLACENTATION
CONTROL OF PROLIFERATION & DIFFERENTIATION
PEDIATRIC AND ADULT CANCERS, LUNG RESEARCH, PHYTOCHEMICAL AND NOVEL THERAPEUTICS
SPECIAL ISSUE: CCNs AND OTHER EXTRACELLULAR MATRIX PROTEINS
MATRIX BIOLOGY, SKIN AGING AND CANCER

JCCS also welcomes the publication of narrative or systematic review articles (between 4000 and 5000 words excluding references) that summarize recent advances and discoveries, identify gaps and debates, and outline future directions in all aspects of cell signaling and communication. JCCS is particularly interested in focused and authoritative mini-reviews (no more than 3000 words excluding references) that will allow the reader to gain a rapid understanding of the material presented on a focused topic.
Inclusion of figures and schematic that help to summarize the major concepts presented is strongly encouraged.
JCCS welcomes Special Issues placed under the scientific responsibility of a guest Editor appointed by the ICCNS. Once the topic of the special issue is validated, the authors invited by the Guest Editor will be requested to submit their manuscript under a section which will be specially open for this Special issue. The timing of publication will be agreed with the Springer Nature production department and the ICCNS/JCCS Administrative Manager and Coordinator.

Short commentaries on recent publications and news that are of interest to the scientific community can be published in the form of JCCS Bits & Bytes which ensure a rapid publication after accelerated reviewing by at least one member of our Editorial Board.Short commentaries on protocols or technical news can be published in the form of Nuts & Bolts. All short commentaries also appear simultaneously on the website of the International CCN Society (http://ccnsociety.com) as soon as they are accepted.
Letters to the Editor are welcome providing that they report original research results of wide interest to the scientific community. Letters typically do not exceed 2-4 pages and report early but ground breaking studies that deserve accelerated processing. The letters undergo strict peer review. The number of figures and or tables is limited to 3. The text is not to exceed 2000 words, and the hnumber of references should be kept to a maximum of 80. The preliminary review process is conducted under the responsibility of an Associate Editor. Manuscripts that do not comply with the 'Letter' requirements can be transferred to regular section Editors.

Editor-in-Chief 
Bernard Perbal
GREDEG, Nice, France 
President of the International CCN Society

Managing Editor
Andrew Leask, University of Western Ontario, Ontario, Canada

Section Editors
Pathology and Translational Research
Andrew Leask, University of Western Ontario, Ontario, Canada
Molecular Signaling
Satoshi Kubota, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan

Reviews
Dieter P. Reinhardt, McGill University, Montreal, Canada
Bits and Bytes
Andrew Leask, University of Western Ontario, Ontario, Canada

Administrative Assistant 
Annick Perbal 

Editorial Board 
David Abraham, University College London, London, UK
K. Ravi Acharya, University of Bath, Bath, UK
Patrick Auberger, INSERM U1065, Nice, France
Sushanta Banerjee, University of Kansas Medical Center, Kansas City MO, USA
George Bou-Gharios, University of Liverpool, Liverpool, UK
Enrique Brandan, Pontificia Universidad Católica de Chile, Chile
Rolf Brekken, The University of Texas Southwestern Medical Center, Dallas TX, USA
David Brigstock, Children's Research Institute, Columbus OH, USA
Carlo Croce, Ohio State University Medical Center, Columbus OH, USA
Mick Dashwood, Royal Free Hospital, London, UK
Marc Diederich, Laboratoire de Biologie Moléculaire et Cellulaire du Cancer, Luxembourg
Gary Fisher, University of Michigan Mecial School, Ann Arbor MI, USA
Roel Goldschmeding, University Medical Center Utrecht, Utrecht, The Netherlands
Donald Gullberg, University of Bergen, Bergen, Norway
Sandra Irvine, Queen's University Belfast, Belfast, Northern Ireland
Celina Kleer, University of Michigan, Ann Arbor MI, USA
Akira Kudo, Tokyo Institute of Technology, Tokyo, Japan
Paul Lasko, McGill University, Montreal QC, Canada
Lester Lau, University of Illinois, Chicago IL, USA
Jack Lawler, Beth Israel Deaconess Medical Center, Boston MA, USA
Zhiyong Lin, Case Western Reserve University, Cleveland OH, USA 
Kathryn E Meier, Washington State University, Spokane, WA, USA 
Kohei Miyazono, University of Tokyo, Tokyo, Japan
Joanne E. Murphy-Ullrich, University of Alabama, Birmingham AL, USA
Kunimasa Ohta, Kumamoto University, Kumamoto, Japan
Anie Philip, McGill University, Montreal QC, Canada
Lynne-Marie Postovit, University of Alberta, Edmonton AB, Canada
David D. Roberts, National Institutes of Health, Bethesda MD, USA
Katia Scotlandi, Istituti Ortopedici Rizzoli, Bologna, Italy
Peter Siegel, McGill University, Montreal QC, Canada
Ulf Smith, University of Gothenburg, Sweden
Masaharu Takigawa, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan
Philip C. Trackman, Boston University, Boston MA, USA
Stephen Twigg, Royal Prince Alfred Hospital, Sydney, Australia
Ralf Weiskirchen, Aachen University Hospital, Germany
Denys Wheatley, BioMedES Ltd., Aberdeenshire, UK
Zhaolin Yang, Cold Spring Harbor, New York, USA
Herman Yeger, The Hospital for Sick Children, Toronto, Canada

Advisory Board 
Robert Baxter, University of Sydney, St Leonards, Australia
Edward Calabrese, University of Massachusetts, Amherst MA, USA 
Meenhard Herlyn, The Wistar Institute, Philadelphia PA, USA
Piero Picci, Istituti Rizzoli, Bologna, Italy
Bernard Roizman, University of Chicago, Chicago IL, USA